aluates Reports

$ 0.0

Automative

Global Antiandrogen Market Insights, Forecast to 2030

Published Date: November 2024

Report Code: QYRE-Auto-19M13001

Global Antiandrogen Market Research Report 2023

BUY CHAPTERS

Global Antiandrogen Market Insights, Forecast to 2030

Code: QYRE-Auto-19M13001

Report

November 2024

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

Orion Corporation

Hengrui

Schering Plough

Hinova Pharma

Jiangsu Hengrui Pharmaceuticals

Sanofi

Merck

Astellas

Astrazeneca plc

Bayer

Antiandrogen Market Size

The global Antiandrogen market is projected to grow from US$ 7180 million in 2024 to US$ 9956.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.

Antiandrogen Market

Market Analysis and Insights: Global Antiandrogen Market

The US & Canada market for Antiandrogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Antiandrogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Antiandrogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Antiandrogen include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui and Bayer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Antiandrogen is widely used in various fields, such as Prostate Cancer, Benign Prostatic Hyperplasia, Polycystic Ovary Syndrome (POCS) and Others, etc. Prostate Cancer provides greatest supports to the Antiandrogen industry development. In 2023, global % revenue of Antiandrogen went into Prostate Cancer filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Antiandrogen market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antiandrogen, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antiandrogen, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antiandrogen revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antiandrogen market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antiandrogen revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Antiandrogen Market Report

Report Metric	Details
Report Name	Antiandrogen Market
Accounted market size in 2024	US$ 7180 million
Forecasted market size in 2030	US$ 9956.5 million
CAGR	5.6
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Steroidal Antiandrogen Nonsteroidal Antiandrogen
Segment by Application	Prostate Cancer Benign Prostatic Hyperplasia Polycystic Ovary Syndrome (POCS) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antiandrogen in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiandrogen companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiandrogen revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Antiandrogen Market growing?

Ans: The Antiandrogen Market witnessing a CAGR of 5.6 during the forecast period 2024-2030.

What is the Antiandrogen Market size in 2030?

Ans: The Antiandrogen Market size in 2030 will be US$ 9956.5 million.

Who are the main players in the Antiandrogen Market report?

Ans: The main players in the Antiandrogen Market are Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals

What are the Application segmentation covered in the Antiandrogen Market report?

Ans: The Applications covered in the Antiandrogen Market report are Prostate Cancer, Benign Prostatic Hyperplasia, Polycystic Ovary Syndrome (POCS), Others

What are the Type segmentation covered in the Antiandrogen Market report?

Ans: The Types covered in the Antiandrogen Market report are Steroidal Antiandrogen, Nonsteroidal Antiandrogen

Recommended Reports

Oncology and Cancer

Urology and Men's Health

Hormonal and Reproductive

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antiandrogen Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Steroidal Antiandrogen

1.2.3 Nonsteroidal Antiandrogen

1.3 Market by Application

1.3.1 Global Antiandrogen Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Prostate Cancer

1.3.3 Benign Prostatic Hyperplasia

1.3.4 Polycystic Ovary Syndrome (POCS)

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antiandrogen Market Perspective (2019-2030)

2.2 Global Antiandrogen Growth Trends by Region

2.2.1 Antiandrogen Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Antiandrogen Historic Market Size by Region (2019-2024)

2.2.3 Antiandrogen Forecasted Market Size by Region (2025-2030)

2.3 Antiandrogen Market Dynamics

2.3.1 Antiandrogen Industry Trends

2.3.2 Antiandrogen Market Drivers

2.3.3 Antiandrogen Market Challenges

2.3.4 Antiandrogen Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Antiandrogen by Players

3.1.1 Global Antiandrogen Revenue by Players (2019-2024)

3.1.2 Global Antiandrogen Revenue Market Share by Players (2019-2024)

3.2 Global Antiandrogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Antiandrogen, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Antiandrogen Market Concentration Ratio

3.4.1 Global Antiandrogen Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antiandrogen Revenue in 2023

3.5 Global Key Players of Antiandrogen Head office and Area Served

3.6 Global Key Players of Antiandrogen, Product and Application

3.7 Global Key Players of Antiandrogen, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antiandrogen Breakdown Data by Type

4.1 Global Antiandrogen Historic Market Size by Type (2019-2024)

4.2 Global Antiandrogen Forecasted Market Size by Type (2025-2030)

5 Antiandrogen Breakdown Data by Application

5.1 Global Antiandrogen Historic Market Size by Application (2019-2024)

5.2 Global Antiandrogen Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Antiandrogen Market Size (2019-2030)

6.2 North America Antiandrogen Market Size by Type

6.2.1 North America Antiandrogen Market Size by Type (2019-2024)

6.2.2 North America Antiandrogen Market Size by Type (2025-2030)

6.2.3 North America Antiandrogen Market Share by Type (2019-2030)

6.3 North America Antiandrogen Market Size by Application

6.3.1 North America Antiandrogen Market Size by Application (2019-2024)

6.3.2 North America Antiandrogen Market Size by Application (2025-2030)

6.3.3 North America Antiandrogen Market Share by Application (2019-2030)

6.4 North America Antiandrogen Market Size by Country

6.4.1 North America Antiandrogen Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Antiandrogen Market Size by Country (2019-2024)

6.4.3 North America Antiandrogen Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Antiandrogen Market Size (2019-2030)

7.2 Europe Antiandrogen Market Size by Type

7.2.1 Europe Antiandrogen Market Size by Type (2019-2024)

7.2.2 Europe Antiandrogen Market Size by Type (2025-2030)

7.2.3 Europe Antiandrogen Market Share by Type (2019-2030)

7.3 Europe Antiandrogen Market Size by Application

7.3.1 Europe Antiandrogen Market Size by Application (2019-2024)

7.3.2 Europe Antiandrogen Market Size by Application (2025-2030)

7.3.3 Europe Antiandrogen Market Share by Application (2019-2030)

7.4 Europe Antiandrogen Market Size by Country

7.4.1 Europe Antiandrogen Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Antiandrogen Market Size by Country (2019-2024)

7.4.3 Europe Antiandrogen Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Antiandrogen Market Size (2019-2030)

8.2 China Antiandrogen Market Size by Type

8.2.1 China Antiandrogen Market Size by Type (2019-2024)

8.2.2 China Antiandrogen Market Size by Type (2025-2030)

8.2.3 China Antiandrogen Market Share by Type (2019-2030)

8.3 China Antiandrogen Market Size by Application

8.3.1 China Antiandrogen Market Size by Application (2019-2024)

8.3.2 China Antiandrogen Market Size by Application (2025-2030)

8.3.3 China Antiandrogen Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Antiandrogen Market Size (2019-2030)

9.2 Asia Antiandrogen Market Size by Type

9.2.1 Asia Antiandrogen Market Size by Type (2019-2024)

9.2.2 Asia Antiandrogen Market Size by Type (2025-2030)

9.2.3 Asia Antiandrogen Market Share by Type (2019-2030)

9.3 Asia Antiandrogen Market Size by Application

9.3.1 Asia Antiandrogen Market Size by Application (2019-2024)

9.3.2 Asia Antiandrogen Market Size by Application (2025-2030)

9.3.3 Asia Antiandrogen Market Share by Application (2019-2030)

9.4 Asia Antiandrogen Market Size by Region

9.4.1 Asia Antiandrogen Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Antiandrogen Market Size by Region (2019-2024)

9.4.3 Asia Antiandrogen Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Antiandrogen Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Antiandrogen Market Size by Type

10.2.1 Middle East, Africa, and Latin America Antiandrogen Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Antiandrogen Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Antiandrogen Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Antiandrogen Market Size by Application

10.3.1 Middle East, Africa, and Latin America Antiandrogen Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Antiandrogen Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Antiandrogen Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Antiandrogen Market Size by Country

10.4.1 Middle East, Africa, and Latin America Antiandrogen Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Antiandrogen Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Antiandrogen Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Antiandrogen Introduction

11.1.4 Pfizer Revenue in Antiandrogen Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Antiandrogen Introduction

11.2.4 Johnson & Johnson Revenue in Antiandrogen Business (2019-2024)

11.2.5 Johnson & Johnson Recent Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Antiandrogen Introduction

11.3.4 AstraZeneca Revenue in Antiandrogen Business (2019-2024)

11.3.5 AstraZeneca Recent Developments

11.4 Astellas

11.4.1 Astellas Company Details

11.4.2 Astellas Business Overview

11.4.3 Astellas Antiandrogen Introduction

11.4.4 Astellas Revenue in Antiandrogen Business (2019-2024)

11.4.5 Astellas Recent Developments

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Antiandrogen Introduction

11.5.4 Merck Revenue in Antiandrogen Business (2019-2024)

11.5.5 Merck Recent Developments

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Antiandrogen Introduction

11.6.4 Sanofi Revenue in Antiandrogen Business (2019-2024)

11.6.5 Sanofi Recent Developments

11.7 Orion Corporation

11.7.1 Orion Corporation Company Details

11.7.2 Orion Corporation Business Overview

11.7.3 Orion Corporation Antiandrogen Introduction

11.7.4 Orion Corporation Revenue in Antiandrogen Business (2019-2024)

11.7.5 Orion Corporation Recent Developments

11.8 Hengrui

11.8.1 Hengrui Company Details

11.8.2 Hengrui Business Overview

11.8.3 Hengrui Antiandrogen Introduction

11.8.4 Hengrui Revenue in Antiandrogen Business (2019-2024)

11.8.5 Hengrui Recent Developments

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Antiandrogen Introduction

11.9.4 Bayer Revenue in Antiandrogen Business (2019-2024)

11.9.5 Bayer Recent Developments

11.10 Schering-Plough

11.10.1 Schering-Plough Company Details

11.10.2 Schering-Plough Business Overview

11.10.3 Schering-Plough Antiandrogen Introduction

11.10.4 Schering-Plough Revenue in Antiandrogen Business (2019-2024)

11.10.5 Schering-Plough Recent Developments

11.11 Hinova Pharma

11.11.1 Hinova Pharma Company Details

11.11.2 Hinova Pharma Business Overview

11.11.3 Hinova Pharma Antiandrogen Introduction

11.11.4 Hinova Pharma Revenue in Antiandrogen Business (2019-2024)

11.11.5 Hinova Pharma Recent Developments

11.12 Jiangsu Hengrui Pharmaceuticals

11.12.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.12.3 Jiangsu Hengrui Pharmaceuticals Antiandrogen Introduction

11.12.4 Jiangsu Hengrui Pharmaceuticals Revenue in Antiandrogen Business (2019-2024)

11.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

Orion Corporation

Hengrui

Schering Plough

Hinova Pharma

Jiangsu Hengrui Pharmaceuticals

Sanofi

Merck

Astellas

Astrazeneca plc

Bayer

List of Tables

Table 1. Global Antiandrogen Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Steroidal Antiandrogen

Table 3. Key Players of Nonsteroidal Antiandrogen

Table 4. Global Antiandrogen Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Antiandrogen Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Antiandrogen Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Antiandrogen Market Share by Region (2019-2024)

Table 8. Global Antiandrogen Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Antiandrogen Market Share by Region (2025-2030)

Table 10. Antiandrogen Market Trends

Table 11. Antiandrogen Market Drivers

Table 12. Antiandrogen Market Challenges

Table 13. Antiandrogen Market Restraints

Table 14. Global Antiandrogen Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Antiandrogen Revenue Share by Players (2019-2024)

Table 16. Global Top Antiandrogen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiandrogen as of 2023)

Table 17. Global Antiandrogen Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Antiandrogen Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Antiandrogen, Headquarters and Area Served

Table 20. Global Key Players of Antiandrogen, Product and Application

Table 21. Global Key Players of Antiandrogen, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antiandrogen Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Antiandrogen Revenue Market Share by Type (2019-2024)

Table 25. Global Antiandrogen Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Antiandrogen Revenue Market Share by Type (2025-2030)

Table 27. Global Antiandrogen Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Antiandrogen Revenue Share by Application (2019-2024)

Table 29. Global Antiandrogen Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Antiandrogen Revenue Share by Application (2025-2030)

Table 31. North America Antiandrogen Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Antiandrogen Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Antiandrogen Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Antiandrogen Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Antiandrogen Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Antiandrogen Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Antiandrogen Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Antiandrogen Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Antiandrogen Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Antiandrogen Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Antiandrogen Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Antiandrogen Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Antiandrogen Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Antiandrogen Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Antiandrogen Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Antiandrogen Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Antiandrogen Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Antiandrogen Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Antiandrogen Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Antiandrogen Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Antiandrogen Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Antiandrogen Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Antiandrogen Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Antiandrogen Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Antiandrogen Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Antiandrogen Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Antiandrogen Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Antiandrogen Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Antiandrogen Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Antiandrogen Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Antiandrogen Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Antiandrogen Market Size by Country (2025-2030) & (US$ Million)

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Antiandrogen Product

Table 66. Pfizer Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 67. Pfizer Recent Developments

Table 68. Johnson & Johnson Company Details

Table 69. Johnson & Johnson Business Overview

Table 70. Johnson & Johnson Antiandrogen Product

Table 71. Johnson & Johnson Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 72. Johnson & Johnson Recent Developments

Table 73. AstraZeneca Company Details

Table 74. AstraZeneca Business Overview

Table 75. AstraZeneca Antiandrogen Product

Table 76. AstraZeneca Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 77. AstraZeneca Recent Developments

Table 78. Astellas Company Details

Table 79. Astellas Business Overview

Table 80. Astellas Antiandrogen Product

Table 81. Astellas Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 82. Astellas Recent Developments

Table 83. Merck Company Details

Table 84. Merck Business Overview

Table 85. Merck Antiandrogen Product

Table 86. Merck Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 87. Merck Recent Developments

Table 88. Sanofi Company Details

Table 89. Sanofi Business Overview

Table 90. Sanofi Antiandrogen Product

Table 91. Sanofi Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 92. Sanofi Recent Developments

Table 93. Orion Corporation Company Details

Table 94. Orion Corporation Business Overview

Table 95. Orion Corporation Antiandrogen Product

Table 96. Orion Corporation Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 97. Orion Corporation Recent Developments

Table 98. Hengrui Company Details

Table 99. Hengrui Business Overview

Table 100. Hengrui Antiandrogen Product

Table 101. Hengrui Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 102. Hengrui Recent Developments

Table 103. Bayer Company Details

Table 104. Bayer Business Overview

Table 105. Bayer Antiandrogen Product

Table 106. Bayer Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 107. Bayer Recent Developments

Table 108. Schering-Plough Company Details

Table 109. Schering-Plough Business Overview

Table 110. Schering-Plough Antiandrogen Product

Table 111. Schering-Plough Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 112. Schering-Plough Recent Developments

Table 113. Hinova Pharma Company Details

Table 114. Hinova Pharma Business Overview

Table 115. Hinova Pharma Antiandrogen Product

Table 116. Hinova Pharma Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 117. Hinova Pharma Recent Developments

Table 118. Jiangsu Hengrui Pharmaceuticals Company Details

Table 119. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 120. Jiangsu Hengrui Pharmaceuticals Antiandrogen Product

Table 121. Jiangsu Hengrui Pharmaceuticals Revenue in Antiandrogen Business (2019-2024) & (US$ Million)

Table 122. Jiangsu Hengrui Pharmaceuticals Recent Developments

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antiandrogen Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Antiandrogen Market Share by Type: 2023 VS 2030

Figure 3. Steroidal Antiandrogen Features

Figure 4. Nonsteroidal Antiandrogen Features

Figure 5. Global Antiandrogen Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Antiandrogen Market Share by Application: 2023 VS 2030

Figure 7. Prostate Cancer Case Studies

Figure 8. Benign Prostatic Hyperplasia Case Studies

Figure 9. Polycystic Ovary Syndrome (POCS) Case Studies

Figure 10. Others Case Studies

Figure 11. Antiandrogen Report Years Considered

Figure 12. Global Antiandrogen Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Antiandrogen Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Antiandrogen Market Share by Region: 2023 VS 2030

Figure 15. Global Antiandrogen Market Share by Players in 2023

Figure 16. Global Top Antiandrogen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiandrogen as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Antiandrogen Revenue in 2023

Figure 18. North America Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Antiandrogen Market Share by Type (2019-2030)

Figure 20. North America Antiandrogen Market Share by Application (2019-2030)

Figure 21. North America Antiandrogen Market Share by Country (2019-2030)

Figure 22. United States Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Antiandrogen Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Antiandrogen Market Share by Type (2019-2030)

Figure 26. Europe Antiandrogen Market Share by Application (2019-2030)

Figure 27. Europe Antiandrogen Market Share by Country (2019-2030)

Figure 28. Germany Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Antiandrogen Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Antiandrogen Market Share by Type (2019-2030)

Figure 36. China Antiandrogen Market Share by Application (2019-2030)

Figure 37. Asia Antiandrogen Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Antiandrogen Market Share by Type (2019-2030)

Figure 39. Asia Antiandrogen Market Share by Application (2019-2030)

Figure 40. Asia Antiandrogen Market Share by Region (2019-2030)

Figure 41. Japan Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Antiandrogen Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Antiandrogen Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Antiandrogen Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Antiandrogen Market Share by Country (2019-2030)

Figure 51. Brazil Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Antiandrogen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Pfizer Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 58. Johnson & Johnson Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 59. AstraZeneca Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 60. Astellas Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 61. Merck Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 62. Sanofi Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 63. Orion Corporation Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 64. Hengrui Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 65. Bayer Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 66. Schering-Plough Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 67. Hinova Pharma Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 68. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Antiandrogen Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Men and Women Hair Loss Market Insights Forecast to 2030

Global Benign Prostatic Hyperplasia Treatment Market Insights Forecast to 2030

Global Osteoporosis Treatment Market Insights Forecast to 2030

Global Anti Fatigue Cosmetics Market Insights Forecast to 2030

Global Anti PD 1 MAb Market Insights Forecast to 2030

Global Atherosclerosis Drugs Market Insights Forecast to 2030

Global Sleep Aids Market Insights Forecast to 2030

Global Natural Appetite Suppressants Market Insights Forecast to 2030

Global Fitness Application Market Insights Forecast to 2030

Global Antithrombotic Agent Market Insights Forecast to 2030

Global Angioedema Treatment Market Insights Forecast to 2030

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Cryotherapy Market Insights Forecast to 2030

Global H2 Antagonist Market Insights Forecast to 2030

Global Drug Discovery Assays Market Insights Forecast to 2030

Global Sperm Separation Systems Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Fertility Solutions Market Insights Forecast to 2030

Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions